Empatica

Executive Summary

Empatica is an Italian digital health company pioneering AI-enabled wearable medical devices and digital biomarkers for remote patient monitoring, with a strong focus on neurology. Its FDA-cleared and CE-certified platforms address critical conditions such as epilepsy and Parkinson's disease, aiming to improve patient outcomes through continuous, real-world data collection. By providing end-to-end solutions for clinical research and patient care, Empatica positions itself at the intersection of wearable technology and precision medicine. The company's validated sensors and algorithms enable objective tracking of physiological signals, reducing reliance on subjective patient diaries and enabling earlier intervention. With a foundation in academic research and a growing body of clinical evidence, Empatica is poised to expand its footprint in neurology and beyond, capitalizing on the shift toward decentralized clinical trials and remote monitoring. Despite a competitive landscape, its regulatory approvals and focus on high-need neurological indications differentiate it from broader wearable health platforms.

Upcoming Catalysts (preview)

• Q2 2026FDA Clearance for Epilepsy Seizure Detection in Pediatric Population70% success
• Q3 2026Major Partnership with a Top-10 Pharma Company for Digital Biomarker Integration in Parkinson's Trials60% success
• Q4 2026Completion of Series C Funding Round to Fund US Commercial Expansion75% success